Is the Symptom Checker Dead? Infermedica CEO Piotr Orzechowski on AI Triage & Medical AI

In this episode of Digital Health Inside Out, Alex Koshykov and Sergei Polevikov sit down with Piotr Orzechowski, founder and CEO of Infermedica, one of the most established companies in AI-powered symptom assessment and clinical triage. We discuss how the symptom-checker category has changed, why standalone consumer symptom checkers may be “dead,” and why clinical-grade AI triage is still becoming more important within real healthcare workflows. Piotr shares the story of building Infermedica from Poland into a global healthtech company, the challenges of selling medical AI internationally, how Infermedica competes in the age of ChatGPT and LLMs, and why medical device certification, physician validation, liability, and evidence still matter. We also cover AI accuracy claims, peer-reviewed validation, neurosymbolic AI, voice-based triage, fundraising for founders from Eastern Europe, the future of AI diagnosis, and what kind of companies might eventually acquire Infermedica. If you care about healthcare AI, digital health, symptom checkers, clinical triage, LLMs in medicine, or the future of regulated medical AI, this conversation is for you. Guest: Piotr Orzechowski — CEO @ Infermedica   / piotrorzechowski1   https://infermedica.com/ Co-Host: Alex Koshykov — CEO @ YODD, COO @ BeKey.io   / alex-koshykov      / @bekey-hub   Co-Host: Sergei Polevikov @sergeiAI — Founder of AI Health Uncut   / sergeiai   AI Health Uncut: https://FixHealth.ai Timecodes: 00:28 — Intro and welcome 01:40 — Piotr’s background and the origin story of Infermedica 05:21 — Fun stories about sharing a name with a musician 06:53 — Is the “symptom checker” category still alive? 07:39 — Why standalone symptom checkers are disappearing 08:22 — AI triage as part of real healthcare workflows 09:10 — Competing with ChatGPT, Claude, Google, and new AI startups 10:54 — Why clinician-built and validated AI still matters 11:46 — Medical device certification and regulatory responsibility 12:38 — Liability, accountability, and why enterprises care 13:40 — What changed in digital health after COVID 15:10 — Building a healthtech company from Poland 16:54 — Piotr’s first Silicon Valley experience 20:32 — How Poland’s startup ecosystem changed over time 22:05 — Sergei’s past criticism of Infermedica and Piotr’s response 25:06 — Moving toward peer-reviewed evidence 27:17 — How buyers and journalists should evaluate AI accuracy claims 29:04 — Why triage accuracy is harder than diagnosis accuracy 30:35 — Real-world data vs. artificial vignettes 31:21 — Why providers care more about workflow than accuracy claims 33:40 — How Infermedica evolved after ChatGPT 37:07 — Conversational triage, chat, voice, and medical device certification 37:51 — Who does Infermedica compete with today? 40:48 — Infermedica’s fundraising journey 44:14 — Founder's responsibility to investors and employees 45:42 — Who could acquire Infermedica in the future? 47:22 — Infermedica’s enterprise pipeline and sales strength 48:26 — Piotr’s bold prediction for AI in healthcare 50:06 — Human-in-the-loop AI and clinical responsibility 51:26 — Why autonomous AI diagnosis should require stronger regulation 52:16 — Sergei’s story from HLTH and the Infermedica unicorn 53:40 — Founder culture, humility, and being hands-on 54:25 — Closing thoughts Thank you for watching this episode of Digital Health Inside Out. If you enjoyed this conversation, please like the video, subscribe to the channel, and share your thoughts in the comments: Will AI triage become a standard part of healthcare workflows, or will patients simply keep using general-purpose tools like ChatGPT? And of course, please subscribe — Sergey gets very sad when you watch without subscribing. Our previous interview with Christina Farr on AI Scribes, IPO Windows, Big Tech Failures, and Health Tech Media:    • Christina Farr on AI Scribes, IPO Windows,...   #DigitalHealth #HealthcareAI #symptomchecker #HealthTech #DigitalHealthInsideOut #AIinHealthcare #HealthTechStartups #VentureCapital #HealthcareInnovation #IPO #AmbientScribing #BigTech